Subissi L, Otieno JR, Worp N, Cohen HA, Munnink BBO, Abu-Raddad LJ, Alm E, Barakat A, Barclay WS, Bhiman JN, Caly L, Chand M, Chen M, Cullinane A, de Oliveira T, Drosten C, Druce J, Effler P, Masry IE, Faye A, Ghedin E, Grant R, Haagmans BL, Happi C, Herring BL, Hodcroft EM, Ikejezie J, Katawera V, Kassamali ZA, Leo YS, Leung GM, Kondor RJ, Marklewitz M, Mendez-Rico J, Melhem NM, Munster V, Nahapetyan K, Naindoo D, Oh DY, Peacock TP, Peiris M, Peng Z, Poon LLM, Rambaut A, Saha S, Shen Y, Siqueira MM, Volz E, Tessema SK, Thiel V, Triki H, van der Werf S, von Eije K, Cunningham J, Koopmans MPG, von Gottberg A, Agrawal A, van Kerkhove MD (2024)

Nature medicine 47

WHO technical advisory group on virus evolution

UKHSA variant technical group

PANGO designation committee

Microsoc, 2023 (talk)

Negative sense viruses, 2022 (talk and poster)

Options X, 2019 (talk)

Contact

Trim content

® The Pirbright Institute 2024 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.